Sartorius AG VZO Stock

Price

Target price

/ Tradegate WKN: 716563 / Symbol: SUVPF / Name: Sartorius / Stock / Healthcare Equipment & Supplies / Mid Cap /

Please give a prediction to see the opinions of the community

sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

JS chart by amCharts

From: to:

Zoom:

Loading data...

Your prediction

Sartorius AG VZO Stock

Sartorius AG VZO shows a slight decrease today, losing -€0.600 (-0.290%) compared to yesterday.

Our community identified positive and negative aspects for Sartorius AG VZO stock for the coming years. 1 users see the criterium "Credit Rating" as a plus for the Sartorius AG VZO stock. On the other hand our users think that "Expected dividend yield" could be a problem in the future.

What does Sartorius do?

Pros and Cons of Sartorius AG VZO in the next few years

Pros

B****

C******** o* t** e**********

G***** c******* t* c**********

Cons

W********* I********* f** t** n*** y****

S********** s********

M***** P*******

Tell us your opinion to access the 'Wisdom of the Crowds'

Your Opinion

Legal notice

Performance of Sartorius AG VZO vs. its peers

Security	Change(%)	1w	1m	1y	YTD	3y	5y
Sartorius AG VZO
Sartorius AG ST
Omnicell Inc.
Healthequity Inc.

sharewise BeanCounterBot

The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.

Last updated at 2024-08-01

Analyzing the financials of Sartorius (US Symbol: SUVPF), a player in the Healthcare Equipment & Supplies industry, offers insights into its operational effectiveness and growth potential. The financial reports from 2021 to 2023 reveal a scenario of considerable growth, albeit accompanied by challenges regarding profitability and investor expectations. The company exhibits a robust revenue stream with an impressive operating margin, but the high price-to-earnings ratios might signal overvaluation, raising questions about market sentiment versus actual earnings growth potential.

Significant Revenue Growth: Over the past few years, Sartorius has demonstrated a notable increase in total revenue, reaching approximately €3.34 billion in 2023, up from around €3.45 billion in 2022 and €2.92 billion in 2021. This consistent upward trajectory indicates strong demand for the company's products and a solid market position.

Healthy EBITDA: With an EBITDA of €779.8 million in 2023, Sartorius showcases its ability to generate substantial earnings before interest, tax, depreciation, and amortization. This figure is a strong indicator of the company's core operational efficiency and suggests that it can generate cash flow fairly comfortably, supporting operations and future investments.

Feedback